CClinicalTrials.gg
Not yet recruitingNCT07668245AQoLStrokeUpdated Jun 30, 2026

Effectiveness of Attention Focus Training on Attention and Quality of Life in Stroke

An interventional study of Exercise and Conventional in Stroke, sponsored by Shifa Tameer-e-Millat University. Not yet recruiting at 1 site in Pakistan. Open to participants aged Up to 55 Years. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Shifa Tameer-e-Millat University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
Up to 55 Years
Sex
All
01

Study summary

This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Intervention will be provided for 4 weeks. Outcomes will be assessed at baseline and after provision of intervention.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Attention
  • Quality of life
  • Stroke
03

Who can participate

Ages eligible
Up to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants diagnosed with stroke
  • Able to ambulate at least with assistance
  • Medically stable

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment (MMSE \< 24)
  • Pre-existing dementia
  • Visual/hearing impairment
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Attention Focus Training with Conventional therapy

    The training group will address the four core components of attention: focus, sustained, selective and alternating attention. Additionally, conventional therapy for stroke will be given.

    Other: Exercise · Other: Conventional

  • Active comparator
    Conventional therapy

    Conventional therapy for stroke will be given

    Other: Conventional

Interventions

  • OtherExercise

    Focused attention (auditory target detection), Sustained attention (letter cancellation), Selective attention (cancellation with distractors), Alternating attention (number-letter switching)

  • OtherConventional

    Positioning and bed mobility, sitting balance training, standing training

05

What researchers measure

Primary outcomes

  1. Test of Everyday Attention

    Test of Everyday Attention (TEA) consists of multiple subtests assessing different aspects of attention. There is no single overall score with a defined minimum and maximum range. Each subtest has its own scoring range and is interpreted using age-adjusted normative data and percentile ranks. For all subtests, higher scores generally indicate better attentional performance.

    Time frame: Baseline and post 4 weeks of intervention

  2. Stroke Impact Scale

    Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke.

    Time frame: Baseline and post 4 weeks of intervention

06

Study locations

1 site
  • Shifa Tameer-e-Millat University
    Islamabad, Pakistan
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07668245
Lead sponsor
Shifa Tameer-e-Millat University
Responsible party
Shafaq Altaf (Assistant Professor, Shifa Tameer-e-Millat University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jul 3, 2026 (estimated)
Primary completion
Sep 3, 2026 (estimated)
Completion
Oct 3, 2026 (estimated)
Last update
Jun 30, 2026

Study contacts

Shafaq Altaf, PhD
Contact
shafaq_dpt.ahs@stmu.edu.pk
+92 343 5020507

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion